← SynDRA
CINOXACIN
SynDRA canonical compound SYN0004579 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | urinary tract infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CA2
- TOP2A; TOP2B
- gyrA
- gyrB
Mechanisms of action (all sources)
- topoisomerase inhibitor
- Inhibitor
- gyrA INHIBITOR
- gyrB INHIBITOR
Drug classes
- Anti-Infective Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- cinobac
- cinobactin
- Cinoxacine
- Cinoxacino
- 64716
- NSC-304467
- Cinobac
- Cinobactin
- Cinoxacinum
- Cinx
- Clinoxacin
- Uronorm
- Azolinic Acid
- C 8645
- Lilly 64716
- TNP00246
- Cinobac (TN)
- Cinoxacine [INN-French]
- Cinoxacino [INN-Spanish]
- Cinoxacinum [INN-Latin]
- Cinoxacin (JAN/USP/INN)
- Cinoxacin [USAN:BAN:INN:JAN]
- 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid
- 1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
- 1-Ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
- 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid
- 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
- LMK22VUH23
- NSC 304467
- CHEBI:3716
- DTXCID202822
- Acid, Azolinic
- cinoxacina
- 1-ethyl-4-oxo-(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid
- RefChem:56762
- J01MB06
- Compound 64716
- MLS000069630
Look up CINOXACIN in the interactive SynDRA portal →